Vaccination and Malaria Prevention among International Travelers Departing from Athens International Airport to African Destinations
Table 2
Vaccine prophylaxis according to destination*.
(%)
Sub-Saharan Africa
North Africa
South Africa
Routine vaccines**
Hepatitis A
108 (49.8)
8 (6.4)
2 (11.1)
Tetanus/diphtheria
95 (43.8)
6 (4.8)
2 (11.1)
Hepatitis B
36 (16.3)
2 (1.6)
0 (0)
Poliomyelitis
39 (18.1)
0 (0)
0 (0)
Measles, Mumps, Rubella
13 (6.1)
0 (0)
0 (0)
Influenza
7 (3.3)
1 (0.8)
0 (0)
Pneumococcal
5 (2.3)
0 (0)
0 (0)
Travel vaccines
Typhoid fever
61 (28)
2 (1.6)
0 (0)
Cholera
6 (2.8)
0 (0)
0 (0)
Yellow fever
104 (48)
0 (0)
0 (0)
Meningococcal (A, C, W135, Y)
58 (26.6)
0 (0)
0 (0)
Rabies
7 (3.3)
0 (0)
0 (0)
Tick-born*** encephalitis
5 (2.3)
0 (0)
0 (0)
Japanese encephalitis****
5 (2.3)
0 (0)
0 (0)
Vaccination was administered to 136 travelers (37.8%).
**In accordance with the National Vaccination Program of Greece.
***Recent vaccination for a trip to tick-born encephalitis endemic countries.
****It was administered to travelers with South East Asia as a second destination.
